Access Clinical Program News Today

Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa News provided by Share this article Up to 200,000 Johnson & Johnson Ebola vaccine regimens will be made available as part of a WHO early access clinical program now underway in Sierra Leone Companys Ebola vaccine regimen also receives Prequalification from the WHO The Johnson & Johnson vaccine regimen is designed to be used proactively to induce immunity against Ebola in adults and children N...